In Reply We agree with Drs Chan and Misra that it is difficult to review and certify large numbers of mHealth apps and that conducting traditional randomized clinical trials of specific apps may not be reasonable given the current rate of innovation. However, we also believe it is problematic to ask clinicians and patients to fend for themselves when evaluating apps. The new challenges that the rapid innovation in apps present may require new types of solutions.